Adipocyte-Specific Hnrnpa1 Knockout Aggravates Obesity-Induced Metabolic Dysfunction via Upregulation of CCL2
© 2024 by the American Diabetes Association..
Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) is involved in lipid and glucose metabolism via mRNA processing. However, whether and how HNRNPA1 alters adipocyte function in obesity remain obscure. Here, we found that the obese state downregulated HNRNPA1 expression in white adipose tissue (WAT). The depletion of adipocyte HNRNPA1 promoted markedly increased macrophage infiltration and expression of proinflammatory and fibrosis genes in WAT of obese mice, eventually leading to exacerbated insulin sensitivity, glucose tolerance, and hepatic steatosis. Mechanistically, HNRNPA1 interacted with Ccl2 and regulated its mRNA stability. Intraperitoneal injection of CCL2-CCR2 signaling antagonist improved adipose tissue inflammation and systemic glucose homeostasis. Furthermore, HNRNPA1 expression in human WAT was negatively correlated with BMI, fat percentage, and subcutaneous fat area. Among individuals with 1-year metabolic surgery follow-up, HNRNPA1 expression was positively related to percentage of total weight loss. These findings identify adipocyte HNRNPA1 as a link between adipose tissue inflammation and systemic metabolic homeostasis, which might be a promising therapeutic target for obesity-related disorders.
ARTICLE HIGHLIGHTS:.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
---|---|
Enthalten in: |
Diabetes - 73(2024), 5 vom: 01. Apr., Seite 713-727 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Xiaoya [VerfasserIn] |
---|
Links: |
---|
Themen: |
CCL2 protein, human |
---|
Anmerkungen: |
Date Completed 22.04.2024 Date Revised 27.04.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.2337/db23-0609 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368096785 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368096785 | ||
003 | DE-627 | ||
005 | 20240427232054.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240207s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2337/db23-0609 |2 doi | |
028 | 5 | 2 | |a pubmed24n1390.xml |
035 | |a (DE-627)NLM368096785 | ||
035 | |a (NLM)38320300 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Xiaoya |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adipocyte-Specific Hnrnpa1 Knockout Aggravates Obesity-Induced Metabolic Dysfunction via Upregulation of CCL2 |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.04.2024 | ||
500 | |a Date Revised 27.04.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024 by the American Diabetes Association. | ||
520 | |a Heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) is involved in lipid and glucose metabolism via mRNA processing. However, whether and how HNRNPA1 alters adipocyte function in obesity remain obscure. Here, we found that the obese state downregulated HNRNPA1 expression in white adipose tissue (WAT). The depletion of adipocyte HNRNPA1 promoted markedly increased macrophage infiltration and expression of proinflammatory and fibrosis genes in WAT of obese mice, eventually leading to exacerbated insulin sensitivity, glucose tolerance, and hepatic steatosis. Mechanistically, HNRNPA1 interacted with Ccl2 and regulated its mRNA stability. Intraperitoneal injection of CCL2-CCR2 signaling antagonist improved adipose tissue inflammation and systemic glucose homeostasis. Furthermore, HNRNPA1 expression in human WAT was negatively correlated with BMI, fat percentage, and subcutaneous fat area. Among individuals with 1-year metabolic surgery follow-up, HNRNPA1 expression was positively related to percentage of total weight loss. These findings identify adipocyte HNRNPA1 as a link between adipose tissue inflammation and systemic metabolic homeostasis, which might be a promising therapeutic target for obesity-related disorders | ||
520 | |a ARTICLE HIGHLIGHTS: | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Heterogeneous Nuclear Ribonucleoprotein A1 |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
650 | 7 | |a CCL2 protein, human |2 NLM | |
650 | 7 | |a Chemokine CCL2 |2 NLM | |
700 | 1 | |a Su, Yingying |e verfasserin |4 aut | |
700 | 1 | |a Xu, Yiting |e verfasserin |4 aut | |
700 | 1 | |a Hu, Tingting |e verfasserin |4 aut | |
700 | 1 | |a Lu, Xuhong |e verfasserin |4 aut | |
700 | 1 | |a Sun, Jingjing |e verfasserin |4 aut | |
700 | 1 | |a Li, Wenfei |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Jian |e verfasserin |4 aut | |
700 | 1 | |a Ma, Xiaojing |e verfasserin |4 aut | |
700 | 1 | |a Yang, Ying |e verfasserin |4 aut | |
700 | 1 | |a Bao, Yuqian |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetes |d 1952 |g 73(2024), 5 vom: 01. Apr., Seite 713-727 |w (DE-627)NLM000060011 |x 1939-327X |7 nnns |
773 | 1 | 8 | |g volume:73 |g year:2024 |g number:5 |g day:01 |g month:04 |g pages:713-727 |
856 | 4 | 0 | |u http://dx.doi.org/10.2337/db23-0609 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 73 |j 2024 |e 5 |b 01 |c 04 |h 713-727 |